Skip to content

Conversational Hypnosis for Peripherical Veinous Access (HYPNACESS)

Analgesia Assessment of Conversational Hypnosis Script During Peripherical Veinous Catheter Set up Versus Standard Script in Operating Room

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04358094
Acronym
HYPNACESS
Enrollment
200
Registered
2020-04-22
Start date
2020-05-04
Completion date
2021-01-18
Last updated
2020-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Access Site Pain

Brief summary

The peripherical veinous catheterization is required for anesthesia. However, it's a painful procedure and causes stress or even phobia. Hypnosis can be seen as an interesting tool. Conversational hypnosis needs no training. It is used by script, which makes it easier. The working hypothesis for study is that the conversational hypnosia script reduces pain during the set up of peripherical veinous access. The main objective is the analgesia assessment of conversational hypnosis script for peripherical veinous catheter set up versus standard script in operating room. A nurse anesthetist is reading the conversational script or standard script during the procedure. The nurse anesthetist is untrained for hypnosis. The secondary objective are the level of anxiety, patient satisfaction within the perioperative period (EVAN G questionnaire), the heart rate and the evaluation how nurse anesthetist feels about using the script after each use.

Interventions

OTHERConversational hypnosis script

Conversational hypnosis during peripherical veinous catheter set up

Standard script during peripherical veinous catheter set up

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Digestive endoscopy procedure under general anesthesia in one of the participating centers * Patient speaking and understanding French * Patient affiliated or entitled to a social security scheme * Patient who received enlightened information about the study and who co-signed, with the investigator, a consent to participate after a minimum period of reflection

Exclusion criteria

* Patient with deafness * Patient with cognitive impairment * Pregnant and / or breastfeeding patient * Patient with dissociative disorders (contraindication to hypnosis) * Patient suffering from a pathology which can cause chronic pain * Patient receiving analgesia or anxiety drug * Patient under justice, curatorship or tutorship * Patient deprived of liberty by judicial or administrative decision

Design outcomes

Primary

MeasureTime frameDescription
Analgesia assessment by digital pain scaleimmediately after applying the peripherical veinous catheter dressingDigital pain scale: it describes the severity of the pain On this scale, 0 represents no pain and 10 represents the worst possible pain

Secondary

MeasureTime frameDescription
Level of anxiety by numerical scalebefore randomization and immediately after peripherical veinous catheter set upDigital scale: it describes the severity of the pain On this scale, 0 represents no anxiety and 10 represents the worst possible anxiety
patient satisfaction within the perioperative period (EVAN G questionnaire)between 4 and 48 hours after the procedureEVAN G questionnaire: Score from 0 to 100 The higher the score, the higher the level of patient satisfaction
Heart rateduring the proceduremaximum heart rate
Nurse anesthetist feeling about using the script after each use by digital scaleimmediately after procedureEvaluate how nurse anesthetist feels about using the script after each use by digital scale ranging from 0 to 10. On this scale, 0 represents uncomfortable and 10 represents very comfortable

Countries

France

Contacts

Primary ContactHervé Bouaziz, Pr
h.bouaziz@chru-nancy.fr0383851403

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026